Characterising persons diagnosed with HIV as either recent or long-term using a cross-sectional analysis of recent infection surveillance data collected in Malawi from September 2019 to March 2020.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 09 2022
Historique:
entrez: 24 9 2022
pubmed: 25 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

In Malawi, a recent infection testing algorithm (RITA) is used to characterise infections of persons newly diagnosed with HIV as recent or long term. This paper shares results from recent HIV infection surveillance and describes distribution and predictors. Data from 155 health facilities in 11 districts in Malawi were pooled from September 2019 to March 2020. Eligible participants were ≥13 years, and newly diagnosed with HIV. Clients had RITA recent infections if the rapid test for recent infection (RTRI) test result was recent and viral load (VL) ≥1000 copies/mL; if VL was <1000 copies/mL the RTRI result was reclassified as long-term. Results were stratified by age, sex, pregnancy/breastfeeding status and district. 13 838 persons consented to RTRI testing and 12 703 had valid RTRI test results and VL results after excluding clients not newly HIV-positive, RTRI negative or missing data (n=1135). A total of 12 365 of the 12 703 were included in the analysis after excluding those whose RTRI results were reclassified as long term (n=338/784 or 43.1%). The remainder, 446/12 703 or 3.5%, met the definition of RITA recent infection. The highest percentage of recent infections was among breastfeeding women (crude OR (COR) 3.2; 95% CI 2.0 to 5.0), young people aged 15-24 years (COR 1.6; 95% CI 1.3 to 1.9) and persons who reported a negative HIV test within the past 12 months (COR 3.3; 95% CI 2.6 to 4.2). Factors associated with recent infection in multivariable analysis included being a non-pregnant female (adjusted OR (AOR) 1.4; 95% CI 1.2 to 1.8), a breastfeeding female (AOR 2.2; 95% CI 1.4 to 3.5), aged 15-24 years (AOR 1.6; 95% CI 1.3 to 1.9) and residents of Machinga (AOR 2.0; 95% CI 1.2 to 3.5) and Mzimba (AOR 2.4; 95% CI 1.3 to 4.5) districts. Malawi's recent HIV infection surveillance system demonstrated high uptake and identified sub-populations of new HIV diagnoses with a higher percentage of recent infections.

Identifiants

pubmed: 36153024
pii: bmjopen-2022-064707
doi: 10.1136/bmjopen-2022-064707
pmc: PMC9511604
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e064707

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2012;7(3):e33328
pubmed: 22479384
J Clin Virol. 2010 Jul;48(3):180-3
pubmed: 20537582
Lancet HIV. 2021 May;8(5):e284-e293
pubmed: 33667411
J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):399-407
pubmed: 33136736
J Clin Virol. 2017 Jul;92:56-61
pubmed: 28531553
JAMA. 1998 Jul 1;280(1):42-8
pubmed: 9660362
Int J STD AIDS. 2000 Aug;11(8):503-8
pubmed: 10990334
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):329-334
pubmed: 35239633
Am J Epidemiol. 1995 Jan 15;141(2):166-72
pubmed: 7817972
AIDS. 2014 Sep 10;28(14):2133-45
pubmed: 25062091
Curr HIV/AIDS Rep. 2015 Jun;12(2):207-15
pubmed: 25855338
J Int AIDS Soc. 2021 Mar;24(3):e25687
pubmed: 33749155
AIDS. 2016 Sep 24;30(15):2361-71
pubmed: 27454561
AIDS Care. 2015;27(5):561-9
pubmed: 25671409
Med Care. 2010 Dec;48(12):1071-9
pubmed: 21063228
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):543-550
pubmed: 30222659
J Acquir Immune Defic Syndr. 2020 May 1;84(1):5-9
pubmed: 32058458
BMC Public Health. 2019 Nov 11;19(1):1507
pubmed: 31711447
Trials. 2017 Jul 24;18(1):349
pubmed: 28738857
J Adolesc Health. 2021 Mar;68(3):497-507
pubmed: 32792256
J Int AIDS Soc. 2020 Jun;23 Suppl 3:e25513
pubmed: 32602625
AIDS. 2014 Oct 23;28(16):2439-49
pubmed: 25144218
J Int AIDS Soc. 2010 Oct 27;13:41
pubmed: 20979651
PLoS One. 2022 Feb 11;17(2):e0262071
pubmed: 35148312
JAMA. 2008 Aug 6;300(5):540-9
pubmed: 18677026
J Acquir Immune Defic Syndr. 2007 Sep;46 Suppl 1:S3-8
pubmed: 17713423
AIDS. 2019 Dec 15;33 Suppl 3:S295-S302
pubmed: 31805029
PLoS One. 2016 May 19;11(5):e0155498
pubmed: 27195800
J Clin Microbiol. 2005 Sep;43(9):4441-7
pubmed: 16145089
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
PLoS One. 2018 Dec 21;13(12):e0209586
pubmed: 30576388
AIDS. 2019 Jul 15;33(9):1527-1529
pubmed: 31021850

Auteurs

Malango T Msukwa (MT)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Ellen W MacLachlan (EW)

Department of Global Health, I-TECH, University of Washington, Seattle, Washington, USA emaclach@uw.edu.

Salem T Gugsa (ST)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Joe Theu (J)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Ireen Namakhoma (I)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Fred Bangara (F)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Christopher L Blair (CL)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Danielle Payne (D)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Kathryn G Curran (KG)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Melissa Arons (M)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Khumbo Namachapa (K)

Department of HIV and AIDS, Ministry of Health, Lilongwe, Central Region, Malawi.

Nellie Wadonda (N)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Alinune N Kabaghe (AN)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Trudy Dobbs (T)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Vedapuri Shanmugam (V)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Evelyn Kim (E)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Andrew Auld (A)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Yusuf Babaye (Y)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Gabrielle O'Malley (G)

Department of Global Health, I-TECH, University of Washington, Seattle, Washington, USA.

Rose Nyirenda (R)

Department of HIV and AIDS, Ministry of Health, Lilongwe, Central Region, Malawi.

George Bello (G)

Department of Global Health, I-TECH, University of Washington, Lilongwe, Malawi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH